Patient21

Patient21 is a Germany-based startup founded in 2019 with a mission to modernize healthcare and redefine primary care. The company's slogan "Redefining primary care" captures its core objective of improving the doctor-patient relationship and facilitating seamless collaboration across medical specialties. Patient21 aims to revolutionize the healthcare industry by leveraging data to provide personalized treatments and offering a holistic view of patients' health through its network of experts.

The company recently secured a substantial $76.00M Series C investment on 22 May 2023, with an impressive lineup of investors including Target Global, PICO Partners, Pitango Venture Capital, Piton Capital, Bertelsmann Investments, Mario Kohle, Maria Raga, and Artian Investments. Patient21's commitment to empowering patients and doctors to make informed decisions, combined with its strategic vision for the future of healthcare, makes it a compelling investment opportunity in the Health Care and Health and Wellness industries. The company's emphasis on universal access to data and collaboration across the healthcare ecosystem positions it as a potential disruptor in the traditional healthcare landscape.

For more information, refer to Patient21's Imprint: https://patient21.com/en/impressum and Privacy: https://patient21.com/privacy.